Preanalytical aspects and sample quality assessment in metabolomics studies of human blood.

BACKGROUND Metabolomics is a powerful tool that is increasingly used in clinical research. Although excellent sample quality is essential, it can easily be compromised by undetected preanalytical errors. We set out to identify critical preanalytical steps and biomarkers that reflect preanalytical inaccuracies. METHODS We systematically investigated the effects of preanalytical variables (blood collection tubes, hemolysis, temperature and time before further processing, and number of freeze-thaw cycles) on metabolomics studies of clinical blood and plasma samples using a nontargeted LC-MS approach. RESULTS Serum and heparinate blood collection tubes led to chemical noise in the mass spectra. Distinct, significant changes of 64 features in the EDTA-plasma metabolome were detected when blood was exposed to room temperature for 2, 4, 8, and 24 h. The resulting pattern was characterized by increases in hypoxanthine and sphingosine 1-phosphate (800% and 380%, respectively, at 2 h). In contrast, the plasma metabolome was stable for up to 4 h when EDTA blood samples were immediately placed in iced water. Hemolysis also caused numerous changes in the metabolic profile. Unexpectedly, up to 4 freeze-thaw cycles only slightly changed the EDTA-plasma metabolome, but increased the individual variability. CONCLUSIONS Nontargeted metabolomics investigations led to the following recommendations for the preanalytical phase: test the blood collection tubes, avoid hemolysis, place whole blood immediately in ice water, use EDTA plasma, and preferably use nonrefrozen biobank samples. To exclude outliers due to preanalytical errors, inspect the biomarker signal intensities reflecting systematic as well as accidental and preanalytical inaccuracies before processing the bioinformatics data.

[1]  W. Willett,et al.  Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome , 2006, BMC clinical pathology.

[2]  I. Wilson,et al.  Metabolite profiles from dried biofluid spots for metabonomic studies using UPLC combined with oaToF-MS. , 2010, Journal of proteome research.

[3]  A. Smilde,et al.  Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. , 2006, Analytical chemistry.

[4]  Frank Suits,et al.  The impact of delayed storage on the measured proteome and metabolome of human cerebrospinal fluid. , 2011, Clinical chemistry.

[5]  Lihua Huang,et al.  Characterization of poly(ethylene glycol) and PEGylated products by LC/MS with postcolumn addition of amines. , 2009, Analytical chemistry.

[6]  Irena Spasic,et al.  A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols. , 2008, International journal of epidemiology.

[7]  Georgios Theodoridis,et al.  UPLC-MS-based analysis of human plasma for metabonomics using solvent precipitation or solid phase extraction. , 2009, Journal of proteome research.

[8]  Joshua D. Knowles,et al.  Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry , 2011, Nature Protocols.

[9]  E. Fukusaki,et al.  Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies. , 2010, Journal of bioscience and bioengineering.

[10]  Ivano Bertini,et al.  Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks , 2011, Journal of biomolecular NMR.

[11]  U. Ceglarek,et al.  Preanalytical standardization of amino acid and acylcarnitine metabolite profiling in human blood using tandem mass spectrometry , 2011, Metabolomics.

[12]  G. Siuzdak,et al.  Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. , 2006, Analytical chemistry.

[13]  Xin Lu,et al.  A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry. , 2009, Molecular bioSystems.

[14]  Xin Lu,et al.  Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information. , 2008, Analytical chemistry.

[15]  Brian C Sweatman,et al.  Optimisation of collection, storage and preparation of rat plasma for 1H NMR spectroscopic analysis in toxicology studies to determine inherent variation in biochemical profiles. , 2002, Journal of pharmaceutical and biomedical analysis.

[16]  G. Theodoridis,et al.  Sample preparation prior to the LC-MS-based metabolomics/metabonomics of blood-derived samples. , 2011, Bioanalysis.

[17]  W. Dudzińska,et al.  The purine metabolism of human erythrocytes , 2006, Biochemistry (Moscow).

[18]  Xiaohua Wu,et al.  Serum 27-nor-5β-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer. , 2011, Journal of proteome research.

[19]  R. Gerszten,et al.  Metabolomics and cardiovascular biomarker discovery. , 2012, Clinical chemistry.

[20]  Henrik Antti,et al.  Predictive metabolomics evaluation of nutrition-modulated metabolic stress responses in human blood serum during the early recovery phase of strenuous physical exercise. , 2009, Journal of proteome research.

[21]  G. Siuzdak,et al.  Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum. , 2006, Analytical chemistry.

[22]  Stephen J. Bruce,et al.  Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. , 2009, Analytical chemistry.

[23]  Mario Plebani,et al.  Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories , 2008, Clinical chemistry and laboratory medicine.

[24]  Johan Trygg,et al.  Evaluation of a protocol for metabolic profiling studies on human blood plasma by combined ultra-performance liquid chromatography/mass spectrometry: From extraction to data analysis. , 2008, Analytical biochemistry.

[25]  Christian Gieger,et al.  Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum , 2008, PLoS genetics.

[26]  J. Bruce German,et al.  Effects of sample handling and storage on quantitative lipid analysis in human serum , 2009, Metabolomics.

[27]  M. Rashed,et al.  Application of electrospray tandem mass spectrometry to neonatal screening. , 1999, Seminars in perinatology.

[28]  M. Gräler,et al.  Erythrocytes store and release sphingosine 1‐phosphate in blood , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Inka J. Appel,et al.  Comparison of serum versus plasma collection in gas chromatography – Mass spectrometry‐based metabolomics , 2010, Electrophoresis.

[30]  Robert S Plumb,et al.  A gender-specific discriminator in Sprague-Dawley rat urine: the deployment of a metabolic profiling strategy for biomarker discovery and identification. , 2007, Analytical biochemistry.

[31]  Alexandros Makriyannis,et al.  Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters , 2008, Clinical chemistry and laboratory medicine.

[32]  Y. Yatomi Plasma sphingosine 1-phosphate metabolism and analysis. , 2008, Biochimica et biophysica acta.

[33]  P. Szecsi,et al.  Error tracking in a clinical biochemistry laboratory , 2009, Clinical chemistry and laboratory medicine.

[34]  G. Lippi,et al.  Preanalytical variability: the dark side of the moon in laboratory testing , 2006, Clinical chemistry and laboratory medicine.

[35]  Kenneth E Blick,et al.  Stability studies of twenty-four analytes in human plasma and serum. , 2002, Clinical chemistry.

[36]  Tobin J Dickerson,et al.  Characterization of differences between blood sample matrices in untargeted metabolomics. , 2011, Analytical chemistry.

[37]  Florian Kronenberg,et al.  Differences between Human Plasma and Serum Metabolite Profiles , 2011, PloS one.

[38]  Mario Plebani,et al.  Exploring the initial steps of the testing process: frequency and nature of pre-preanalytic errors. , 2012, Clinical chemistry.